Purpose: Due to the high prevalence of iron deficiency anemia in women undergoing gynecological surgeries and its association with worse postoperative results, it is necessary to identify and treat anemia preoperatively. However, although anemia and iron deficiency are significant global health problems, there are still disparities in the recognition and implementation of “Patient Blood Management” (PBM) as a comprehensive approach to mitigating the risks associated with these diseases. The purpose of the study is to review best practices for the treatment of anemia based on the Enhanced Recovery After Surgery (ERAS) protocol and PBM recommendations. Methods: This study reviewed the literature on preoperative iron deficiency anemia in patients undergoing gynecological surgery. We identified references through searches in PubMed using relevant search terms. Results: Among the various strategies used in PBM, perhaps the most important is the early detection and management of anemia. In gynecological surgery, there are several approaches to reducing perioperative blood loss, highlighting the use of gonadotropin-releasing hormone (GnRH) agonists (aGnRh) and antifibrinolytics. Oral and intravenous iron supplementation can be performed in addition to blood transfusion to treat anemia. Conclusion: Addressing preoperative and postoperative anemia through systematic correction, following the guidelines of the ERAS protocol and PBM guidelines, is essential to improving perioperative outcomes in women undergoing gynecological surgery.
References
[1]
World Health Organization (2021) The Urgent Need to Implement Patient Blood Management: Policy Brief. https://www.who.int/publications/i/item/9789240035744
[2]
Mirza, F.G., Abdul-Kadir, R., Breymann, C., Fraser, I.S. and Taher, A. (2018) Impact and Management of Iron Deficiency and Iron Deficiency Anemia in Women’s Health. ExpertReviewofHematology, 11, 727-736. https://doi.org/10.1080/17474086.2018.1502081
[3]
Chaparro, C.M. and Suchdev, P.S. (2019) Anemia Epidemiology, Pathophysiology, and Etiology in Low‐ and Middle‐Income Countries. AnnalsoftheNewYorkAcademyofSciences, 1450, 15-31. https://doi.org/10.1111/nyas.14092
[4]
World Health Organization (2001) Iron Deficiency Anaemia: Assessment, Prevention and Control. A Guide for Programme Managers. World Health Organization, Geneva. https://portaldeboaspraticas.iff.fiocruz.br/biblioteca/iron-deficiency-anaemia-assessment-prevention-and-control-a-guide/
[5]
WHO (2021) Anaemia in Women and Children. https://www.who.int/data/gho/data/themes/topics/anaemia_in_women_and_children
[6]
Jadunandan, S., Tano, R., Vicus, D., Callum, J. and Lin, Y. (2022) The Incidence of Perioperative Anemia and Iron Deficiency in Patients Undergoing Gyne-Oncology Surgery. CanadianOncologyNursingJournal, 32, 75-80. https://doi.org/10.5737/236880763217580
[7]
Richards, T., Musallam, K.M., Nassif, J., Ghazeeri, G., Seoud, M., Gurusamy, K.S., etal. (2015) Impact of Preoperative Anaemia and Blood Transfusion on Postoperative Outcomes in Gynaecological Surgery. PLOSONE, 10, e0130861. https://doi.org/10.1371/journal.pone.0130861
[8]
Murji, A., Lam, M., Allen, B., Richard, L., Shariff, S.Z., Austin, P.C., etal. (2019) Risks of Preoperative Anemia in Women Undergoing Elective Hysterectomy and Myomectomy. American Journal of Obstetrics and Gynecology, 221, 629.e1-629.e18. https://doi.org/10.1016/j.ajog.2019.07.018
[9]
Browning, R.M., Trentino, K., Nathan, E.A. and Hashemi, N. (2012) Preoperative Anaemia Is Common in Patients Undergoing Major Gynaecological Surgery and Is Associated with a Fivefold Increased Risk of Transfusion. AustralianandNewZealandJournalofObstetricsandGynaecology, 52, 455-459. https://doi.org/10.1111/j.1479-828x.2012.01478.x
[10]
Muñoz, M., Gómez-Ramírez, S., Kozek-Langeneker, S., Shander, A., Richards, T., Pavía, J., etal. (2015) ‘Fit to Fly’: Overcoming Barriers to Preoperative Haemoglobin Optimization in Surgical Patients. BritishJournalofAnaesthesia, 115, 15-24. https://doi.org/10.1093/bja/aev165
[11]
O’Sullivan, O.E. and O’Reilly, B.A. (2014) Gynecological Surgery and the Robot. Engineering, 6, 59-70. https://doi.org/10.4236/eng.2014.62009
[12]
Rolli, L., Duranti, L. and Leuzzi, G. (2019) Treatment of Anaemia in the “ERAS” Era: How Far Can We Go? JournalofThoracicDisease, 11, 3692-3695. https://doi.org/10.21037/jtd.2019.09.21
[13]
Beattie, W.S., Karkouti, K., Wijeysundera, D.N. and Tait, G. (2009) Risk Associated with Preoperative Anemia in Noncardiac Surgery. Anesthesiology, 110, 574-581. https://doi.org/10.1097/aln.0b013e31819878d3
[14]
Fowler, A.J., Ahmad, T., Phull, M.K., Allard, S., Gillies, M.A. and Pearse, R.M. (2015) Meta-Analysis of the Association between Preoperative Anaemia and Mortality after Surgery. BritishJournalofSurgery, 102, 1314-1324. https://doi.org/10.1002/bjs.9861
[15]
Kotzé, A., Harris, A., Baker, C., Iqbal, T., Lavies, N., Richards, T., etal. (2015) British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre‐Operative Anaemia. BritishJournalofHaematology, 171, 322-331. https://doi.org/10.1111/bjh.13623
[16]
Muñoz, M., Peña‐Rosas, J.P., Robinson, S., Milman, N., Holzgreve, W., Breymann, C., etal. (2017) Patient Blood Management in Obstetrics: Management of Anaemia and Haematinic Deficiencies in Pregnancy and in the Post‐Partum Period: NATA Consensus Statement. TransfusionMedicine, 28, 22-39. https://doi.org/10.1111/tme.12443
[17]
Cançado, R.D. (2023) Iron Deficiency Anemia in Women: Pathophysiological, Diagnosis, and Practical Management. RevistadaAssociaçãoMédicaBrasileira, 69, e2023S112. https://doi.org/10.1590/1806-9282.2023s112
[18]
Camaschella, C. (2015) Iron Deficiency: New Insights into Diagnosis and Treatment. Hematology, 2015, 8-13. https://doi.org/10.1182/asheducation-2015.1.8
[19]
Turner J, Parsi M, Badireddy M (2022) Anemia. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK499994/
[20]
Lin, Y. (2019) Preoperative Anemia-Screening Clinics. Hematology, 2019, 570-576. https://doi.org/10.1182/hematology.2019000061
[21]
Tasbihgou, S.R., Vogels, M.F. and Absalom, A.R. (2017) Accidental Awareness during General Anaesthesia—A Narrative Review. Anaesthesia, 73, 112-122. https://doi.org/10.1111/anae.14124
[22]
Doig, K. (2015) Disorders of Iron Kinetics and Heme Metabolism. In: Keohane, E.M., Otto, C.N. and Walenga, J.M., Eds., Rodak’s Hematology Clinical Applications and Principles, 5th Edition, Saunders, 297-313.
[23]
Munro, M.G., Critchley, H.O.D., Broder, M.S. and Fraser, I.S. (2011) FIGO Classification System (PALM‐COEIN) for Causes of Abnormal Uterine Bleeding in Nongravid Women of Reproductive Age. InternationalJournalofGynecology&Obstetrics, 113, 3-13. https://doi.org/10.1016/j.ijgo.2010.11.011
[24]
Hare, G.M.T. and Mazer, C.D. (2021) Anemia: Perioperative Risk and Treatment Opportunity. Anesthesiology, 135, 520-530. https://doi.org/10.1097/aln.0000000000003870
[25]
Nelson, G., Altman, A.D., Nick, A., Meyer, L.A., Ramirez, P.T., Achtari, C., etal. (2016) Guidelines for Pre-and Intra-Operative Care in Gynecologic/Oncology Surgery: Enhanced Recovery after Surgery (ERAS®) Society Recommendations—Part I. GynecologicOncology, 140, 313-322. https://doi.org/10.1016/j.ygyno.2015.11.015
[26]
Jimenez, K., Kulnigg-Dabsch, S. and Gasche, C. (2015) Management of Iron Deficiency Anemia. Gastroenterology & Hepatology, 11, 241-250.
[27]
Leahy, M.F., Hofmann, A., Towler, S., Trentino, K.M., Burrows, S.A., Swain, S.G., et al. (2017) Improved Outcomes and Reduced Costs Associated with a Health‐System—Wide Patient Blood Management Program: A Retrospective Observational Study in Four Major Adult Tertiary‐Care Hospitals. Transfusion, 57, 1347-1358. https://doi.org/10.1111/trf.14006
[28]
Sixty-Third World Health Assembly (2010) Availability, Safety and Quality of Blood Products. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf
[29]
Hofmann, A., Farmer, S. and Shander, A. (2011) Five Drivers Shifting the Paradigm from Product-Focused Transfusion Practice to Patient Blood Management. TheOncologist, 16, 3-11. https://doi.org/10.1634/theoncologist.2011-s3-3
[30]
Directorate-General for Health and Food Safety (2017) Building National Programmes on Patient Blood Management (PBM) in the EU: A Guide for Health Authorities. Publications Office of the European Union.
[31]
Lopez, A., Cacoub, P., Macdougall, I.C. and Peyrin-Biroulet, L. (2016) Iron Deficiency Anaemia. TheLancet, 387, 907-916. https://doi.org/10.1016/s0140-6736(15)60865-0
[32]
Beutler, E., Hoffbrand, A.V. and Cook, J.D. (2003) Iron Deficiency and Overload. Hematology, 2003, 40-61. https://doi.org/10.1182/asheducation-2003.1.40
[33]
Camaschella, C. (2015) Iron-Deficiency Anemia. NewEnglandJournalofMedicine, 372, 1832-1843. https://doi.org/10.1056/nejmra1401038
[34]
Derman, R., Roman, E., Modiano, M.R., Achebe, M.M., Thomsen, L.L. and Auerbach, M. (2017) A Randomized Trial of Iron Isomaltoside versus Iron Sucrose in Patients with Iron Deficiency Anemia. AmericanJournalofHematology, 92, 286-291. https://doi.org/10.1002/ajh.24633
[35]
Toblli, J. and Angerosa, M. (2014) Optimizing Iron Delivery in the Management of Anemia: Patient Considerations and the Role of Ferric Carboxymaltose. DrugDesign, DevelopmentandTherapy, 8, 2475-2491. https://doi.org/10.2147/dddt.s55499
[36]
Auerbach, M. and Adamson, J.W. (2015) How We Diagnose and Treat Iron Deficiency Anemia. AmericanJournalofHematology, 91, 31-38. https://doi.org/10.1002/ajh.24201
[37]
DeLoughery, T.G. (2019) Safety of Oral and Intravenous Iron. ActaHaematologica, 142, 8-12. https://doi.org/10.1159/000496966
[38]
Bazeley, J.W. and Wish, J.B. (2022) Recent and Emerging Therapies for Iron Deficiency in Anemia of CKD: A Review. AmericanJournalofKidneyDiseases, 79, 868-876. https://doi.org/10.1053/j.ajkd.2021.09.017
[39]
Onken, J.E., Bregman, D.B., Harrington, R.A., Morris, D., Acs, P., Akright, B., etal. (2013) A Multicenter, Randomized, Active‐Controlled Study to Investigate the Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency Anemia. Transfusion, 54, 306-315. https://doi.org/10.1111/trf.12289
[40]
Koch, T.A., Myers, J. and Goodnough, L.T. (2015) Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations. Anemia, 2015, Article 763576. https://doi.org/10.1155/2015/763576
[41]
Evstatiev, R., Marteau, P., Iqbal, T., Khalif, I.L., Stein, J., Bokemeyer, B., etal. (2011) Fergicor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease. Gastroenterology, 141, 846-853.E2. https://doi.org/10.1053/j.gastro.2011.06.005
[42]
Ganz, T., Aronoff, G.R., Gaillard, C.A.J.M., Goodnough, L.T., Macdougall, I.C., Mayer, G., etal. (2020) Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk. KidneyMedicine, 2, 341-353. https://doi.org/10.1016/j.xkme.2020.01.006
[43]
Bolton‐Maggs, P.H.B. and Cohen, H. (2013) Serious Hazards of Transfusion (SHOT) Haemovigilance and Progress Is Improving Transfusion Safety. BritishJournalofHaematology, 163, 303-314. https://doi.org/10.1111/bjh.12547
[44]
Szebeni, J., Fishbane, S., Hedenus, M., Howaldt, S., Locatelli, F., Patni, S., etal. (2015) Hypersensitivity to Intravenous Iron: Classification, Terminology, Mechanisms and Management. BritishJournalofPharmacology, 172, 5025-5036. https://doi.org/10.1111/bph.13268
[45]
Gilli, I.O., Vigorito, A.C. and Benites, B.D. (2019) Revisiting Old Practices: More Restricted Indication of Preoperative Autologous Blood Donation in Healthy Bone Marrow Donors According to Baseline Hemoglobin Levels. Transfusion and ApheresisScience, 58, 323-325. https://doi.org/10.1016/j.transci.2019.04.001
[46]
Szczepiorkowski, Z.M. and Dunbar, N.M. (2013) Transfusion Guidelines: When to Transfuse. Hematology, 2013, 638-644. https://doi.org/10.1182/asheducation-2013.1.638
[47]
Olga, M., Maura, S. and Juan, D. (2020) Diagnosis and Management of Anemia before Gynecologic Surgery. Topics in Obstetrics & Gynecology, 40, 1-6.
[48]
Carson, J.L. (2012) Red Blood Cell Transfusion: A Clinical Practice Guideline from the AABB. AnnalsofInternalMedicine, 157, 49-58. https://doi.org/10.7326/0003-4819-157-1-201206190-00429
[49]
Klein, H.G., Spahn, D.R. and Carson, J.L. (2007) Red Blood Cell Transfusion in Clinical Practice. TheLancet, 370, 415-426. https://doi.org/10.1016/s0140-6736(07)61197-0
[50]
Lethaby, A., Puscasiu, L. and Vollenhoven, B. (2017) Preoperative Medical Therapy before Surgery for Uterine Fibroids. CochraneDatabaseofSystematicReviews, No. 11, CD000547. https://doi.org/10.1002/14651858.cd000547.pub2
Lethaby, A., Vollenhoven, B. and Sowter, M. (2002) Efficacy of Pre‐Operative Gonadotrophin Hormone Releasing Analogues for Women with Uterine Fibroids Undergoing Hysterectomy or Myomectomy: A Systematic Review. BJOG: AnInternationalJournalofObstetrics&Gynaecology, 109, 1097-1108. https://doi.org/10.1111/j.1471-0528.2002.01225.x
[53]
Zhong, Y.J., Zhang, W., Zhang, W.T., Cheng, J., Lü, Q.Y. and Zeng, K.K. (2013) Efficacy and Safety of GnRH—A Combine with Laparoscope Conservative Surgery in the Treatment of the Moderate or Severe Endometriosis. Chinese Journal of Obstetrics and Gynecology, 48, 180-182.
[54]
Colacurci, N., de Franciscis, P., Mollo, A., Mele, D., Fortunato, N. and Zarcone, R. (1998) Pre-Operative GnRH Analogue in Hysteroscopic Metroplasty. Panminerva Medica, 40, 41-44.
[55]
de Milliano, I., Huirne, J.A.F., Thurkow, A.L., Radder, C., Bongers, M.Y., van Vliet, H., etal. (2019) Ulipristal Acetate vs Gonadotropin‐Releasing Hormone Agonists Prior to Laparoscopic Myomectomy (MYOMEX Trial): Short‐Term Results of a Double‐Blind Randomized Controlled Trial. ActaObstetriciaetGynecologicaScandinavica, 99, 89-98. https://doi.org/10.1111/aogs.13713
[56]
Levy, J.H., Koster, A., Quinones, Q.J., Milling, T.J. and Key, N.S. (2018) Antifibrinolytic Therapy and Perioperative Considerations. Anesthesiology, 128, 657-670. https://doi.org/10.1097/aln.0000000000001997
[57]
Heyns, M., Knight, P., Steve, A.K. and Yeung, J.K. (2020) A Single Preoperative Dose of Tranexamic Acid Reduces Perioperative Blood Loss. AnnalsofSurgery, 273, 75-81. https://doi.org/10.1097/sla.0000000000003793
[58]
Ross, J. and Al-Shahi Salman, R. (2012) The Frequency of Thrombotic Events among Adults Given Antifibrinolytic Drugs for Spontaneous Bleeding: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials. CurrentDrugSafety, 7, 44-54. https://doi.org/10.2174/157488612800492744
[59]
Muñoz, M., Acheson, A.G., Auerbach, M., Besser, M., Habler, O., Kehlet, H., etal. (2016) International Consensus Statement on the Peri‐Operative Management of Anaemia and Iron Deficiency. Anaesthesia, 72, 233-247. https://doi.org/10.1111/anae.13773
[60]
Centers for Disease Control and Prevention (1998) Recommendations to Prevent and Control Iron Deficiency in the United States. MMWR Recommendations and Reports. RR-3, 1-29.
[61]
Muñoz, M., Acheson, A.G., Bisbe, E., Butcher, A., Gómez‐Ramírez, S., Khalafallah, A.A., et al. (2018) An International Consensus Statement on the Management of Postoperative Anaemia after Major Surgical Procedures. Anaesthesia, 73, 1418-1431. https://doi.org/10.1111/anae.14358
[62]
Auerbach, M. and Deloughery, T. (2016) Single-Dose Intravenous Iron for Iron Deficiency: A New Paradigm. Hematology, 2016, 57-66. https://doi.org/10.1182/asheducation-2016.1.57
